Form 4: Medtronic Executive Reports Tax-Related Share Disposition

Medtronic EVP Michael Marinaro disposed of 7,471 shares to satisfy tax obligations related to vested restricted stock units.

Summary

• Michael Marinaro, EVP, President of MedSurg and Americas, reported the disposition of 7,471 ordinary shares of Medtronic plc.
• The transaction occurred on June 4, 2026, at a price of $83.32 per share.
• The shares were withheld by the company to satisfy tax withholding obligations resulting from the vesting of performance-based restricted stock units on April 24, 2026.
• Following this transaction, the reporting person maintains a direct beneficial ownership of 63,122 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax settlement rather than a change in executive sentiment or company outlook.

Positives

• The transaction was a mandatory tax withholding event rather than a discretionary open-market sale, indicating continued executive retention of the remaining 63,122 shares.

Negatives

• Reduction in the total number of shares held directly by the executive.

Risks

• None identified; this is a routine administrative transaction related to equity compensation.

Future Outlook

Not applicable as this is a retrospective disclosure of a completed equity transaction.

Industry Context

StockSavvy.ai notes that routine tax-related share withholdings are standard practice for senior executives at large-cap medical device companies like Medtronic, reflecting the settlement of long-term incentive plans.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for executive compensation in the S&P 500.
• The use of 'sell-to-cover' or share withholding for tax obligations is the industry norm for companies such as Abbott Laboratories and Boston Scientific.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related equity settlement.

Key Dates

Keywords

Medtronic, MDT, Insider Trading, Form 4, Equity Compensation, Tax Withholding